IRIS
MANZIA, TOMMASO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.299
AS - Asia 5.122
EU - Europa 3.034
SA - Sud America 632
AF - Africa 94
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 31.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.124
SG - Singapore 2.714
CN - Cina 822
IT - Italia 638
RU - Federazione Russa 524
BR - Brasile 512
HK - Hong Kong 448
VN - Vietnam 382
DE - Germania 344
FI - Finlandia 266
GB - Regno Unito 244
IE - Irlanda 241
UA - Ucraina 209
FR - Francia 157
JP - Giappone 142
IN - India 140
BD - Bangladesh 130
KR - Corea 104
CA - Canada 101
NL - Olanda 89
SE - Svezia 80
MX - Messico 50
ES - Italia 49
AR - Argentina 48
ID - Indonesia 44
TR - Turchia 42
AT - Austria 40
PL - Polonia 37
BE - Belgio 27
ZA - Sudafrica 24
IQ - Iraq 21
EG - Egitto 20
EC - Ecuador 19
CZ - Repubblica Ceca 18
CO - Colombia 15
AU - Australia 14
CH - Svizzera 14
MY - Malesia 12
NG - Nigeria 12
PH - Filippine 12
SA - Arabia Saudita 11
CL - Cile 10
KE - Kenya 10
GR - Grecia 9
HR - Croazia 9
TH - Thailandia 9
UZ - Uzbekistan 9
IR - Iran 8
JO - Giordania 8
TN - Tunisia 8
VE - Venezuela 8
AZ - Azerbaigian 7
EU - Europa 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
MA - Marocco 6
MD - Moldavia 6
PK - Pakistan 6
PY - Paraguay 6
IL - Israele 5
NP - Nepal 5
PE - Perù 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
JM - Giamaica 4
KG - Kirghizistan 4
LK - Sri Lanka 4
PT - Portogallo 4
RO - Romania 4
TM - Turkmenistan 4
DK - Danimarca 3
GT - Guatemala 3
HN - Honduras 3
KH - Cambogia 3
KZ - Kazakistan 3
SN - Senegal 3
TW - Taiwan 3
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
KW - Kuwait 2
LB - Libano 2
ML - Mali 2
MT - Malta 2
NO - Norvegia 2
PA - Panama 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
Totale 31.185
Salva come PNG Salva come JPEG
Città #
Wilmington 5.240
Houston 4.828
Woodbridge 4.195
Singapore 1.245
Fairfield 772
Ashburn 621
San Jose 520
Ann Arbor 469
New York 450
Chandler 444
Hong Kong 435
Beijing 340
Seattle 308
Cambridge 281
Council Bluffs 280
Santa Clara 239
Dublin 232
Helsinki 200
Medford 180
Los Angeles 171
Jacksonville 170
The Dalles 153
Rome 136
Tokyo 128
Ho Chi Minh City 117
Zhengzhou 101
Buffalo 98
Hanoi 94
Elk Grove Village 88
Lawrence 84
Moscow 84
Lauterbourg 78
Dearborn 72
São Paulo 68
Chicago 57
Orem 57
San Diego 50
Milan 48
Creede 45
London 44
Munich 41
Chennai 40
Dallas 39
North Bergen 36
Menlo Park 34
Atlanta 32
Montreal 32
Jakarta 30
Boardman 28
Denver 28
Frankfurt am Main 28
Mülheim 28
Shanghai 28
Toronto 27
Warsaw 26
Nuremberg 25
Brooklyn 23
Nanjing 23
Amsterdam 22
Johannesburg 22
Manchester 22
Palo Alto 22
Poplar 22
Redondo Beach 22
Stockholm 22
Lappeenranta 21
Turin 21
Vienna 21
Brussels 20
Phoenix 20
Mexico City 18
San Francisco 17
Mountain View 16
Norwalk 16
Redwood City 16
Salt Lake City 16
Seoul 16
Jersey City 15
Rio de Janeiro 15
Dong Ket 14
Miami 14
Verona 14
Ankara 13
Hefei 13
Madrid 13
Brasília 12
Engelhard 12
Guangzhou 12
Genoa 11
Istanbul 11
Mumbai 11
Columbus 10
Da Nang 10
Haiphong 10
Padua 10
Boston 9
Curitiba 9
Hounslow 9
Islington 9
Nairobi 9
Totale 24.407
Salva come PNG Salva come JPEG
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 666
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 528
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 527
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 506
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 505
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 497
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 492
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 487
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 482
Use of mycophenolate mofetil in liver transplantation: a literature review. 481
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 475
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 472
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 470
Marginal donors in liver transplantation. 470
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 469
596 460
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 459
Management of spermatic cord liposarcoma in renal transplant recipients: case report 447
Liver abscess caused by foreign body ingestion 447
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 446
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 445
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 444
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 435
Immunosuppression-Free Liver Transplantation 435
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 428
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 428
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 427
Liver transplantation for the treatment of nodular regenerative hyperplasia 422
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 421
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 421
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 418
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 413
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 413
Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. 402
Prospect for kidney bioengineering: Shortcomings of the status quo 392
Myopericytoma of the Liver Hilus: A Case Report 378
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 376
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 372
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 364
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 363
An unusual duodenal polyp causing anemia in a liver-transplanted patient 347
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 339
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 333
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 330
Donation after circulatory death in paediatric liver transplantation: current status and future perspectives in the machine perfusion era 323
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 309
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study 306
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 300
Liver transplantation with a normothermic machine preserved fatty nonagenarian liver: A case report 299
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 290
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 276
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 259
Pandora’s Box: Unpredictable Evolution of a 20-Year History of a Bariatric Patient—Report of Small Bowel Migrated Gastric Band after Redo Banded Gastric Bypass 253
Liver Transplantation For HDV/HBV Coinfection In Italy: An Intention-To-Treat Analysis Of Long-Term Outcomes 246
Rare malignant glomus tumor of the stomach with liver metastases 238
Platelets and hepatocellular cancer: Bridging the bench to the clinics 224
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 224
The COVID-19 outbreak in Italy: initial implications for organ transplantation programs 219
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 212
Liver transplantation for hepatocellular carcinoma: Where do we stand? 209
Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma 209
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 205
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 202
Everolimus and Advagraf Ab Initio in Combined Liver and Kidney Transplant With Donor-Specific Antibodies: A Case Report 197
Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome 196
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 195
How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature 190
Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy) 187
Abdominal organ bioengineering: current status and future perspectives 179
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: A compromise between the risk of recurrence and the risk of rejection? 171
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria–In Patients Waiting for Liver Transplantation 165
Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: Report of a case 156
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group 145
Moving forward in the treatment of cholangiocarcinoma 129
Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study 126
The hamletic dilemma of patients waiting for kidney transplantation during the COVID-19 pandemic: to accept or not to accept (an organ offer)? 121
Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation 120
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 119
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 113
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 106
Pancreatic Adeno-MiNEN, a Rare Newly Defined Entity with Challenging Diagnosis and Treatment: A Case Report with Systematic Literature Review and Pooled Analysis 105
The Enhanced Recovery after Surgery (ERAS) Pathway Is a Safe Journey for Kidney Transplant Recipients during the “Extended Criteria Donor” Era 104
Chronic rejection after liver transplantation: Opening the Pandora's box 104
“Salus Populi Suprema Lex”: Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic 101
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 95
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 95
Cancer mortality after kidney transplantation: A multicenter cohort study in Italy 94
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 94
The Enhanced Recovery After Surgery Pathway Is Safe, Feasible and Cost-Effective in Delayed Graft Function After Kidney Transplant 94
Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation 92
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 90
Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy 89
Safety and efficacy of simultaneous liver transplantation and sleeve gastrectomy in morbid obese patients with end-stage liver disease: the LT-SG study 88
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 87
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 86
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 86
Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study 85
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early (vs delayed) introduction of everolimus in De Novo Kidney transplant recipients, with a follow-up evaluation at 12 months after transplant (NEVERWOUND study) 85
Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis 85
Graft weight integration in the early allograft dysfunction formula improves the prediction of early graft loss after liver transplantation 85
Totale 28.594
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 0 62
2021/2022909 52 87 14 32 24 92 61 28 120 116 54 229
2022/20231.371 138 120 15 144 108 251 106 250 100 12 92 35
2023/2024676 76 38 81 17 93 163 32 12 16 37 8 103
2024/20254.099 94 753 446 230 40 283 306 116 327 347 666 491
2025/20267.115 595 285 623 671 685 446 895 900 805 570 393 247
Totale 31.870